Highlights Oxford Biomedica plc

Equities

OXB

GB00BDFBVT43

Market Closed - London S.E. Other stock markets 11:35:07 2024-04-26 am EDT			5-day change	1st Jan Change
228.5 ^GBX	+3.86%		+12.56%	+3.86%

Apr. 18	Stifel Upgrades Oxford BioMedica to Buy from Hold, Lifts PT	MT
Apr. 18	HSBC likes Haleon, cuts Flutter to 'hold'	AN

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20	AN
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	Mar. 20	MT
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	Mar. 05	AN
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	Mar. 05	CI
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	Jan. 29	MT
Institut Merieux ups stake in Oxford BioMedica toward 10%	Jan. 29	AN
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	Jan. 28	CI
Oxford BioMedica posts optimistic outlook on uptick in contract value	Dec. 07	AN
Oxford Biomedica plc Provides Business Update	Dec. 07	CI
Oxford Biomedica to Buy ABL Europe from Institut Mérieux	Dec. 04	MT
Oxford BioMedica buys ABL Europe for consideration of EUR15 million	Dec. 04	AN
Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.	Dec. 03	CI
Oxford Biomedica plc entered into a sale and purchase agreement to acquire ABL EUROPE S.A.S. from TSGH for ?15 million.	Dec. 03	CI
Oxford BioMedica shares up, in talks to buy ABL Europe but loss widens	23-09-20	AN
Oxford BioMedica Gains 10% Amid Talks to Acquire ABL Europe	23-09-20	MT
Oxford Biomedica Talks to Buy ABL Europe	23-09-20	CI
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe	23-09-20	RE
Earnings Flash (OXB.L) OXFORD BIOMEDICA Posts H1 Revenue GBP43.1M	23-09-20	MT
Earnings Flash (OXB.L) OXFORD BIOMEDICA Posts H1 Loss GBX-49.74	23-09-20	MT
Oxford Biomedica plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Oxford Biomedica plc

Equities

OXB

GB00BDFBVT43

Highlights

Filters